The intensive therapy experienced different results on two of the main element components of this primary result. At the proper time of the changeover, the rate of non-fatal myocardial infarction in the intensive-therapy group was lower than that in the standard-therapy group , but the rate of death from cardiovascular causes was non-significantly higher . These divergent results were retained at the end of the study, with a rate of nonfatal myocardial infarction in the intensive-therapy group that was less than that in the standard-therapy group and an interest rate of loss of life from cardiovascular causes that was higher . Finally, at the proper period of the transition, there is a 21 percent higher level of death from any kind of cause in the intensive-therapy group than in the standard-therapy group and a 19 percent higher rate by the end of the study .The collaboration will combine MicroDose’s leading edge dry powder inhaler technology with 3M’s global inhalation item development, formulation advancement , and manufacturing capabilities. Within the offer, 3M has invested $5 million for a minority equity placement in MicroDose. Collaborating with MicroDose and its strong technology system in dried out powder inhalation will significantly enhance 3M Medication Delivery Systems Division’s capability to provide partner pharmaceutical and biotechnology companies with innovative drug delivery solutions.